(Q40162169)

18 September 2017

1 reference

title

Oxprenolol: clinical pharmacology, pharmacokinetics, and pharmacodynamics (English)

1 reference

18 September 2017

Oxprenolol: Clinical pharmacology, pharmacokinetics, and pharmacodynamics (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Cardiology and cardiovascular medicine

6 October 2023

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

6 October 2023

1 reference

1 reference

M. J. Kendall

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6356863

6 October 2023

V. A. John

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6356863

6 October 2023

language of work or name

English

0 references

publication date

1 November 1983

1 reference

18 September 2017

10 November 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6356863

full work available at URL

6 October 2023

https://api.elsevier.com/content/article/PII:0002914983906392?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

https://api.elsevier.com/content/article/PII:0002914983906392?httpAccept=text/plain

6 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

American Journal of Cardiology

6 October 2023

published in

1 reference

18 September 2017

volume

52

1 reference

18 September 2017

issue

9

1 reference

18 September 2017

page(s)

27D-33D

1 reference

Antihypertensive and hemodynamic effects of oxprenolol versus propranolol

18 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Comparison of the Immediate Effects of Five β-Adrenoreceptor-Blocking Drugs with Different Ancillary Properties in Angina Pectoris

6 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Special article. The role of beta-adrenergic blockade in myocardial infarction

6 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

A long-term prevention study with oxprenolol in coronary heart disease

6 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

The assessment of beta-adrenoceptor blocking drugs in man

6 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Clinical Pharmacokinetics of Propranolol

6 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Bioavailability of conventional and slow-release oxprenolol in fasted and nonfasted individuals

6 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Pharmacokinetics of oxprenolol in normal subjects

6 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation

6 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris

6 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Pharmacokinetics of Nadolol, a Beta-Receptor Antagonist: Administration of Therapeutic Single- and Multiple-Dosage Regimens to Hypertensive Patients

6 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension

6 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Clinical Pharmacokinetics of β-Adrenoreceptor Blocking Drugs

6 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

An investigation of the comparative liposolubilities of β-adrenoceptor blocking agents

6 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Clinical pharmacology of propranolol

6 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man

6 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Variability of beta-blocker pharmacokinetics in young volunteers

6 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Effects of inflammatory disease on plasma oxprenolol concentrations

6 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Comparison of plasma and saliva levels of metoprolol and oxprenolol

6 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Beta-adrenoceptor blockers and the blood-brian barrier

6 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy

6 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Current concepts: beta-blockers in pregnancy

6 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Aromatic hydroxylation of beta-adrenergic antagonists. 4- and 5-hydroxylation of 1-(isopropylamino)-3-[2-(allyloxy)phenoxy]-2-propanol (oxprenolol)

6 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

The metabolites of oxprenolol (Trasicor) in man.

6 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Direct measurement of propranolol bioavailability during accumulation to steady-state

6 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol

6 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Dose-dependent acebutolol disposition after oral administration

6 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Pharmacokinetics of Nadolol, a Beta-Receptor Antagonist: Administration of Therapeutic Single- and Multiple-Dosage Regimens to Hypertensive Patients

6 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Influence of Food on the Bioavailability of Drugs

6 October 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Influence of food and diet on gastrointestinal drug absorption: a review

6 October 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism

6 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Enhancement of the bioavailability of propranolol and metoprolol by food

6 October 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Pharmacokinetics of propranolol, quinidine, procainamide and lidocaine in chronic renal disease

6 October 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease

6 October 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Plasma propranolol concentrations and the erythrocyte sedimentation rate

6 October 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography. Five commonly used beta blockers and hydralazine

6 October 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Evaluation of simple method to check compliance with antihypertensive drug therapy

6 October 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Exercise responses of healthy subjects in the evaluation of cardioselectivity of?-blockers

6 October 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise

6 October 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90639-2

6 October 2023

Identifiers

1 reference

18 September 2017

1 reference